Habas, K. Et Al. 2021. EFFECTS OF AN ESTABLISHED DRUG ON SMAD SIGNALLING PATHWAY IN THE RAT MODEL OF MONOCROTALINE PULMONARY HYPERTENSION. HEART , vol.107 .

Habas, K., ATLI EKLİOĞLU, Ö., & Nasim, T., (2021). EFFECTS OF AN ESTABLISHED DRUG ON SMAD SIGNALLING PATHWAY IN THE RAT MODEL OF MONOCROTALINE PULMONARY HYPERTENSION. HEART , vol.107.

Habas, Khaled, ÖZLEM ATLI EKLİOĞLU, And Talat Nasim. "EFFECTS OF AN ESTABLISHED DRUG ON SMAD SIGNALLING PATHWAY IN THE RAT MODEL OF MONOCROTALINE PULMONARY HYPERTENSION," HEART , vol.107, 2021

Habas, Khaled Et Al. "EFFECTS OF AN ESTABLISHED DRUG ON SMAD SIGNALLING PATHWAY IN THE RAT MODEL OF MONOCROTALINE PULMONARY HYPERTENSION." HEART , vol.107, 2021

Habas, K. ATLI EKLİOĞLU, Ö. And Nasim, T. (2021) . "EFFECTS OF AN ESTABLISHED DRUG ON SMAD SIGNALLING PATHWAY IN THE RAT MODEL OF MONOCROTALINE PULMONARY HYPERTENSION." HEART , vol.107.

@article{article, author={Khaled Habas Et Al. }, title={EFFECTS OF AN ESTABLISHED DRUG ON SMAD SIGNALLING PATHWAY IN THE RAT MODEL OF MONOCROTALINE PULMONARY HYPERTENSION}, journal={HEART}, year=2021}